Literature DB >> 22928754

A systematic review of the effectiveness and cost-effectiveness of bilateral multichannel cochlear implants in adults with severe-to-profound hearing loss.

L Crathorne1, M Bond, C Cooper, J Elston, G Weiner, R Taylor, K Stein.   

Abstract

BACKGROUND: In the UK, approximately 10 000 people have cochlear implants, more than 99% with a unilateral implant. Evidence shows that adults implanted bilaterally may benefit from binaural advantages; however, systematic review evidence is limited. OBJECTIVES OF THE REVIEW: To conduct a systematic review to discover the evidence for effectiveness and cost-effectiveness of using bilateral cochlear implants in adults with severe-to-profound hearing loss by comparing their effectiveness with unilateral cochlear implantation or unilateral cochlear implantation and acoustic hearing aid in the contralateral ear. TYPE OF REVIEW: Systematic review. SEARCH STRATEGY: This examined 16 electronic databases, plus bibliographies and references for published and unpublished studies. EVALUATION
METHOD: Abstracts were independently assessed against inclusion criteria by two researchers, and disagreements were resolved. Selected papers were then retrieved and further independently assessed in a similar way. Included studies had their data extracted by one reviewer and checked by another.
RESULTS: Searches yielded 2892 abstracts producing 19 includable studies. Heterogeneity between studies precluded meta-analysis. However, all studies reported that bilateral cochlear implants improved hearing and speech perception: one randomised controlled trial found a significant binaural benefit over the first ear alone for speech and noise from the front (12.6 ± 5.4%, P < 0.001) and when noise was ipsilateral to the first ear (21 ± 6%, P < 0.001); and another found a significant benefit for spatial hearing at 3 and 9 months post-implantation compared with pre-implantation [mean difference (sd) scores: 3 months = 1.46 (0.83-2.09), P < 0.01].Quality of life results varied, showing bilateral implantation may improve quality of life in the absence of worsening tinnitus. Limited cost-effectiveness evidence showed that bilateral implantation is probably only cost-effective at a willingness-to-pay threshold above £62 000 per quality adjusted life year.
CONCLUSIONS: Despite inconsistency in the quality of available evidence, the robustness of systematic review methods gives weight to the positive findings of included studies demonstrating that bilateral implantation is clinically effective in adults but unlikely to be cost-effective.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22928754     DOI: 10.1111/coa.12011

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  11 in total

1.  Benefits of a contralateral routing of signal device for unilateral Naída CI cochlear implant recipients.

Authors:  Isabelle Mosnier; Ghizlene Lahlou; Jonathan Flament; Nathalie Mathias; Evelyne Ferrary; Olivier Sterkers; Daniele Bernardeschi; Yann Nguyen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-17       Impact factor: 2.503

2.  General Health Quality of Life Instruments Underestimate the Impact of Bilateral Cochlear Implantation.

Authors:  Theodore R McRackan; Joshua E Fabie; Prashant N Bhenswala; Shaun A Nguyen; Judy R Dubno
Journal:  Otol Neurotol       Date:  2019-07       Impact factor: 2.311

3.  Objective and Subjective Measures of Simultaneous vs Sequential Bilateral Cochlear Implants in Adults: A Randomized Clinical Trial.

Authors:  Véronique J C Kraaijenga; Geerte G J Ramakers; Yvette E Smulders; Alice van Zon; Inge Stegeman; Adriana L Smit; Robert J Stokroos; Nadia Hendrice; Rolien H Free; Bert Maat; Johan H M Frijns; Jeroen J Briaire; E A M Mylanus; Wendy J Huinck; Gijsbert A Van Zanten; Wilko Grolman
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-09-01       Impact factor: 6.223

4.  Comparison of Outcomes in Unilateral and Bilateral Pediatric Cochlear Implants: Our Experience.

Authors:  Amit Kumar Anand; Neeraj Suri; Jayachandran Ganesh; Rajesh Vepuri; Rampravesh Kumar; Neha Tiwari
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-03-18

5.  Evidence gaps in economic analyses of hearing healthcare: A systematic review.

Authors:  Ethan D Borre; Mohamed M Diab; Austin Ayer; Gloria Zhang; Susan D Emmett; Debara L Tucci; Blake S Wilson; Kamaria Kaalund; Osondu Ogbuoji; Gillian D Sanders
Journal:  EClinicalMedicine       Date:  2021-05-08

6.  PVDF-Based Piezoelectric Microphone for Sound Detection Inside the Cochlea: Toward Totally Implantable Cochlear Implants.

Authors:  Steve Park; Xiying Guan; Youngwan Kim; Francis Pete X Creighton; Eric Wei; Ioannis John Kymissis; Hideko Heidi Nakajima; Elizabeth S Olson
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

7.  A Preliminary Prototype High-Speed Feedback Control of an Artificial Cochlear Sensory Epithelium Mimicking Function of Outer Hair Cells.

Authors:  Hiroki Yamazaki; Dan Yamanaka; Satoyuki Kawano
Journal:  Micromachines (Basel)       Date:  2020-06-29       Impact factor: 2.891

8.  No Difference in Behavioral and Self-Reported Outcomes for Simultaneous and Sequential Bilateral Cochlear Implantation: Evidence From a Multicenter Randomized Controlled Trial.

Authors:  Véronique J C Kraaijenga; Geerte G J Ramakers; Yvette E Smulders; Alice van Zon; Rolien H Free; Johan H M Frijns; Wendy J Huinck; Robert J Stokroos; Wilko Grolman
Journal:  Front Neurosci       Date:  2019-02-20       Impact factor: 4.677

Review 9.  Bilateral Cochlear Implantation: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2018-10-24

10.  Improvements in Hearing and in Quality of Life after Sequential Bilateral Cochlear Implantation in a Consecutive Sample of Adult Patients with Severe-to-Profound Hearing Loss.

Authors:  Ville Sivonen; Saku T Sinkkonen; Tytti Willberg; Satu Lamminmäki; Hilkka Jääskelä-Saari; Antti A Aarnisalo; Aarno Dietz
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.